Company ProfilePremium

Amco India Limited

Company Profile Analysis

Ticker: 530133.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Amco India Limited - Company showcase

Year Founded & Workforce

1987

79 Employees

Amco India Limited logo

Amco India Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Amco India Limited Overview

Amco India Limited is a promoter-controlled, Delhi-NCR-based micro-cap converter of aluminium foil for flexible and pharmaceutical packaging. Although its legal and historical identity is rooted in PVC — the group began in 1981 with PVC leather cloth and added PVC calendered films and sheeting in 1991 — the company today is, in operational substance, a single-segment aluminium foil business: the PVC Films/Sheeting segment has generated nil revenue in both FY2025 and FY2026, while aluminium foil accounted for 100% of reported quarterly segment revenue throughout FY2026 and Q1 FY2027. The company rolls, anneals, coats, laminates, prints and slits foil at Noida (Uttar Pradesh) and Baddi (Himachal Pradesh), serving blister and strip packaging for Indian pharmaceutical companies (website customer references include Cipla, Hetero, Ajanta Pharma and USV), plus cigarette, milk-powder, pan masala, food-wrap and industrial applications. With revenue of ~INR 118 crore, sub-3% operating margins, no R&D, no exports and no institutional ownership, it is a price-taking niche processor trading below book value.

Sources: FY2026 Annual Report (Directors' Report, MD&A, dated 27 Aug 2026); BSE; company website; Screener.in; Emkay; MarketsMojo; Simply Wall St.


What the company does

Amco India manufactures and converts aluminium foil and foil laminates, and historically manufactured PVC leather cloth (coated fabric) and PVC calendered films and sheeting. According to the company's own product literature, the PVC leather cloth unit coats PVC onto fabric substrates in embossed and printed designs for furnishings, sports shoes and goods, belts and wallets; the PVC films and sheeting unit uses calendering to make material for shower curtains, automotive side door panels and sun visors, stationery, insulation tapes and rainwear. The aluminium foil operation supplies foil in thicknesses from 0.007 mm to 0.2 mm, plain, coated (e.g., VMCH heat-seal lacquer for blister lidding), laminated (with paper or LDPE) and gravure-printed up to multiple colours.

The FY2025 Annual Report's business overview (as summarised by Screener) describes the company as a manufacturer and seller of aluminium foil, PVC film/sheeting, PVC rigid, CCF (likely "cold-form/cold-compression foil" or coated fabric — the abbreviation is not expanded in the source), and non-woven fabrics/laminated fabrics. The FY2026 MD&A additionally references non-woven products using PP granules and pigments as raw materials, indicating at least a historical or residual non-woven line, though no revenue is attributed to it in segment reporting.

Company's own description (paraphrased from FY2026 Annual Report and website)

The company presents itself as a reliable domestic supplier of aluminium foil with a particular focus on pharmaceutical packaging. Management states that it has executed orders for packaging, pharmaceutical and automobile industries; that it now supplies leading players with foil for cigarette packaging, milk-powder packaging and medical/surgical equipment packaging; and that it has positioned itself to benefit from substitution of alternative substrates by foil in products such as gutkha and pan masala. Management's stated intent is to consolidate its position in pharma packaging and to enhance capacity in foil production and coating operations. The website describes the foil range as delivering barrier protection against moisture, light, oxygen and contaminants for packaging, pharmaceuticals, food and beverage, insulation and industrial uses.

Business model and revenue model

DimensionCharacterisation
Revenue model~100% product sales (manufactured and converted foil). No subscription, licensing or service revenue disclosed.
PricingConversion-margin model: aluminium (primary metal / foil stock) cost largely passed through; margin earned on rolling, annealing, coating, lamination, printing and slitting. Pricing tied to LME-linked aluminium prices and INR/USD; no pricing disclosures.
Order patternB2B, order-driven (management uses the phrase "executed orders"); likely a mix of rate contracts with pharma companies and spot business with converters/traders. Not disclosed.
Value chain positionMid-stream converter: buys aluminium (foil stock or re-roll stock) from primary producers or traders → rolls/anneals/coats/laminates/prints → sells to pharma packers, converters, FMCG/tobacco packers and industrial users. Not integrated upstream into smelting or downstream into finished packs.
Customer typesPharmaceutical manufacturers (blister and strip packs), flexible packaging converters, tobacco/pan masala packers, dairy (milk powder), medical device packers, automotive/industrial (heat-exchanger fins, cable wrap), trading houses.
End-marketsPharmaceuticals (core), packaged food & dairy, tobacco/confectionery, medical devices, electrical/cable, HVAC (fins), automotive.
GeographyEffectively 100% domestic India: foreign exchange earnings were INR 0 in FY2026 and INR 23.96 lakh in FY2025.

Independent characterisation

Amco India's identity in data feeds ("PVC leather cloth and aluminium foils"; BSE industry "Plastics – Sheets/Films") lags its economic reality. The PVC business is dormant — PVC segment revenue was INR ~16.4 lakh in FY2024 and nil in FY2025 and FY2026, while PVC capital employed is static at INR 2.83 crore. The company is a small, low-margin aluminium foil converter whose revenue base (~INR 118–124 crore) is heavily driven by metal prices rather than value-added volume. Its operating profit before other income has been between INR 1.2 crore and INR 2.8 crore in each of the last three fiscal years, so non-operating "other income" (INR 1.5–2.1 crore per year) has been comparable to, or larger than, core operating profit — a structural feature that makes reported earnings fragile. Its strategic levers are narrow: capacity utilisation, product mix (printed/coated pharma foil versus plain foil), working-capital discipline and procurement timing. A real-estate side venture (the "Krish Icons" association of persons in Bhiwadi, Rajasthan, 40% profit share) adds diversification of uncertain materiality.

Sources: FY2026 MD&A and Directors' Report; FY2025 Annual Report (via Screener key points); company website products and infrastructure pages; Simply Wall St; ROIC.ai company description.

Strategy

Stated strategy (themes from FY2026 Annual Report, paraphrased)

ThemeManagement articulation (paraphrased)Evidence of execution
Pharma packaging focusConsolidate position as a reliable supplier to pharma packaging; foresees domestic and international pharma demand growthPharma customers on website; blister/strip foil flagship; exports nil
Capacity enhancementWorking towards enhancing capacity in foil production and coatingNet fixed assets declining; FY2026 derived capex ~nil; no capex quantum or timeline disclosed
Product diversification / value-addShift to higher value-added products; new applications (cigarette, milk powder, medical/surgical, pan masala)Mix data not disclosed; Q1 FY2027 margin improvement may reflect mix
New marketsInitiatives to enter new markets across both segments; website states plan to enter international marketsForex earnings fell to nil in FY2026
Operational efficiency & technologyAdopt advanced technologies, improve efficiencies, energy-efficient motors and LED lightingCapital investment in energy-efficient equipment (amount not disclosed)
Risk mitigationStrategic sourcing, efficiency, value-added segments to counter raw-material volatility and competition—
Diversification (real estate)AOP "Krish Icons" with Krish Infrastructures Pvt Ltd for housing in Bhiwadi; 40:60 profit share; units being soldDisclosed under "Joint Ventures" in FY2026 Directors' Report; financial contribution not quantified
PVC segmentManagement describes PVC market growth opportunities but discloses no revival planPVC revenue nil for two years

Initiatives in the last 24 months

InitiativeDateDetail
Governance refreshJun 2024CMD appointment; new independent director
Audit architectureAug 20255-year secretarial auditor; cost auditor; new AoA conforming to Companies Act 2013
Registered office relocationNov 2025Move from Rexine Bazaar to New Friends Colony, New Delhi
Internal auditFeb 2026Sumit R Kumar & Co. appointed
Board strengtheningAug 2026Third independent director (Neeraj Gupta)
Energy conservationFY2026Energy-efficient motors, LEDs; solar street lighting being planned
Physical-share windowDec 2025Regulatory special window for re-lodgement of transfer requests

Medium-term targets / guidance

None. Amco India publishes no quantitative revenue, margin, capex or return targets and holds no earnings calls or investor days. Management's qualitative outlook in the FY2026 Directors' Report expresses confidence in strengthening its competitive position; the MD&A notes the company needs additional funds for working capital and long-term capital to support capacity and sales growth.

Sources: FY2026 Directors' Report and MD&A; company website.

Products & Services

Pricing models for individual products are not publicly disclosed; Amco India does not publish price lists. Launch years are not disclosed except where noted.

Aluminium Foil segment

ProductDescription & key specificationsTarget customers / applicationsNotes
Blister foil (lidding)0.02–0.025 mm hard-temper foil, VMCH heat-seal lacquer coated; plain or printed up to 4 coloursPharma blister packs (tablet/capsule push-through lidding)Website lists "Blister Foil" as flagship; described as accepted by leading pharma companies
Pharma strip foil0.03–0.04 mm soft foil laminated with 150-gauge LDPEPharma strip packs (sachet-style unit dose)Flagship pharma product
Cigarette / label foil0.007 mm foil laminated with paperCigarette inner liners, labelsCompany cites supply to "big" cigarette packers since FY2023
Tea-chest lining / ORS substrate0.008–0.009 mm plain foilTea chests; oral rehydration salt sachet substrate—
Label / lamination foil0.008–0.009 mm laminated with paperLabels, lamination—
Cheese wrap / lamination foil0.012 mm plainCheese wrapping; converter laminations—
Household foil0.012/0.014/0.015 mmFood wrapping—
Soft bare foil0.05/0.064/0.075/0.09 mm, soft temperTagger foil, cable wrap, casseroles/containers—
Fin stock0.12/0.16/0.20 mmFins for heat exchangers (HVAC, automotive radiators)—
Cable wrap (Al-Mylar)0.20 mm bareCable shielding wrap—
Milk-powder packaging foilLaminated foil structures (spec not disclosed)Dairy (milk powder)Cited in FY2026 MD&A as a newer application
Medical/surgical equipment packaging foilLaminated/coated foil (spec not disclosed)Medical device packersCited in FY2026 MD&A
Pan masala / gutkha foilLaminated foil (spec not disclosed)Mouth-freshener/tobacco packersMD&A cites substitution trend
Printed foilGravure printed on 6-colour, 4+3-colour (2 lines) and 2-colour lines at BaddiBranded pharma and FMCG packsBaddi capacity 100+ tonnes/month printed foil
BOPP foil / structuresBiaxially oriented polypropylene-based product listed on websiteFlexible packagingWhether manufactured, laminated or traded is not specified
CPP foil / structuresCast polypropylene-based product listed on websiteFlexible packaging heat-seal layersAs above
Glassine paperSupercalendered, grease-resistant paperRelease liners, food/pharma interleavingWebsite capacity 20+ tonnes/month
Kaneka Gemlac resinsResin product branded "Kaneka Gemlac" listed on the websiteNot described (likely coating/lacquer or PVC-related resin)Nature of relationship with Kaneka (Japan) is not disclosed; likely traded/distributed product. No partnership disclosed in filings

Process capability (Noida): cold rolling mill; in-built beta-gauge thickness controller (radioisotope source: Curium-244, 18.5 GBq / 500 mCi) for uniform gauge; Junker annealing oven with automatic time-temperature control; two lamination machines; two coating machines. Baddi: gravure printing (6-colour single line; 4+3-colour two lines; 2-colour single line), two double-shaft centre-winding slitters with auto-tension and edge guide, two doctoring machines, two core cutters; QC lab with analytical balance (GSM), bursting-strength, seal-strength, pinhole testing, viscosity cup, bond/heat-seal strength testers.

PVC Film/Sheeting segment (dormant)

ProductDescriptionApplicationsStatus
PVC leather cloth (coated fabric)PVC coated on fabric substrates; embossed and printed designsFurnishings, sports shoes/goods, belts, wallets; historically automotiveNo revenue disclosed FY2025–FY2026
PVC calendered films & sheetingFlexible PVC film via calendering (1991 line)Shower curtains, auto side door panels/sun visors, stationery, insulation tapes, rainwear, table covers, suit coversNil revenue FY2025, FY2026
PVC rigidRigid PVC film (referenced in FY2025 AR business overview)Likely pharma blister forming film/stationeryNot reported separately
Non-woven fabrics / laminated fabricsPP-based non-woven (raw materials PP granules and pigments)Not specifiedReferenced in FY2025 AR and FY2026 MD&A; no segment revenue

Sources: company website (products, infrastructure, home pages); FY2026 MD&A; FY2025 Annual Report key points via Screener; ROIC.ai description.

Financial Narrative

Basis: Standalone, Ind AS, INR crore. FY2024–FY2026 rebuilt from Screener quarterly data and reconciled to audited PBT/PAT (Directors' Report FY2026: PBT INR 51.22 lakh FY2026, INR 228.37 lakh FY2025; PAT INR 33.10 lakh and INR 187.45 lakh). FY2022–FY2023 from Screener annual data (rounded to INR 1 crore; PAT derived from EPS × 41.10 lakh shares). FY2021 shown in prose for CAGR purposes (revenue ~INR 88 crore; PAT ~INR 1.47 crore).

Income statement

Gross profit: not disclosed on a consistent annual basis. S&P data (Simply Wall St) shows TTM to 31 Dec 2025 gross profit of INR 10.26 crore on revenue of ~INR 110 crore (gross margin ~9.1%, defined as revenue less cost of materials). EBIT ("operating income" in US terms) = EBITDA incl. other income less D&A: FY2024 2.24, FY2025 3.47, FY2026 1.56. Diluted EPS equals basic (no dilutive instruments). FY2022 PBT derived from 29% tax rate; FY2023 PBT from 35% tax rate (Screener). The FY2026 Screener annual row shows OPM 1.7%, which does not reconcile with its own quarterly data (1.0%); the quarterly-reconciled figure is used.

Revenue CAGR: FY2021→FY2026 (5-year): +6.0% (INR 88 crore → INR 117.76 crore; Screener reports 5.91%). FY2022→FY2026 (4-year): -6.8%. FY2023→FY2026 (3-year): -8.7% (Screener: -9%). PAT CAGR FY2021→FY2026: approximately -26% (INR 1.47 crore → INR 0.33 crore).

Company-reported FY2026 MD&A ratios (note definitional differences): Operating profit margin ratio -1.26% (FY2025: -1.79%) — the company's definition evidently excludes other income and deducts finance and depreciation charges, producing negative values; Net profit ratio 0.29% (FY2025: 1.79%).

Commentary — income statement.

  1. The FY2022 spike and FY2024 collapse are price and mix effects, not franchise changes. Revenue rose 77% in FY2022 (to INR 156 crore) as aluminium prices surged post-pandemic and PVC still contributed; FY2024 revenue fell 33% as aluminium prices normalised and PVC revenue disappeared (INR ~16 lakh). Operating margin peaked at 4.1% in FY2022 — inventory gains in a rising-metal environment are a likely contributor — and has not exceeded 3% since.

  2. Other income is structurally large relative to operations. In FY2024 other income (INR 2.10 crore) was 1.7× operating profit; in FY2026 (INR 1.50 crore) 1.3×. The nature of other income (interest on deposits/advances, real-estate AOP share, scrap, rentals) is not itemised in the sources accessed. Screener flags that "earnings include an other income of INR 1.50 crore." Without it, FY2026 would have been loss-making at PBT level.

  3. FY2026: revenue up 11.8%, profit down 82%. Management attributes the decline to lower EBIT; MD&A and the Directors' Report cite intense competition and raw-material price volatility, and state that rupee movements significantly affected foil sales. Q1 FY2026 was loss-making (PBT -INR 0.14 crore at 0.27% OPM) and Q4 FY2026 OPM was 0.38%.

  4. Q1 FY2027 inflection. Revenue INR 32.18 crore (+23.5% YoY), OPM 4.44% (highest in the 13-quarter series), PAT INR 0.94 crore — already ~2.8× FY2026's full-year PAT. One quarter does not establish a trend, particularly given the company's history of single strong quarters (e.g., Q3 FY2025 OPM 3.82% followed by Q4 FY2025 at 0.29%).

Quarterly series

Source: Screener.in quarterly results (C-MOTS), cross-checked to Capital Market/JM Financial (Q1 FY2027: sales 32.18, OPM 4.44%, PBDT 1.54, PBT 1.27, NP 0.94) and company filings (Q1 FY2027 revenue INR 3,217.92 lakh; PBT INR 127.49 lakh; PAT INR 94.34 lakh; company-reported EPS INR 2.30 vs Screener 2.29 — rounding). Q4 FY2025 tax rate of -105.88% reflects a deferred tax credit.

TTM (Q2 FY2026–Q1 FY2027): Revenue INR 123.89 crore; operating profit INR 2.52 crore (2.0%); other income INR 1.50 crore; PBT INR 1.92 crore; PAT INR 1.40 crore; EPS INR 3.40.

Balance sheet

Source: Screener balance sheet (rounded). Book value per share INR 92.1 (Screener, 31 Mar 2026) implies net worth of ~INR 37.9 crore. Company-reported debt/equity 0.34 (FY2026 and FY2025) is consistent with ~INR 13 crore of borrowings.

Commentary — balance sheet. The balance sheet is small and conservatively levered, with net worth compounding slowly (INR 34 crore → INR 38 crore over four years) because profits are thin and retained in full. Borrowings fell from INR 17 crore (FY2022) to INR 10 crore (FY2024) as revenue (and thus working capital) shrank, then rose to INR 13 crore in FY2025 as receivables and inventory days lengthened. "Other liabilities" jumped from INR 8 crore to INR 13 crore in FY2026 and "other assets" from INR 40 crore to INR 47 crore — consistent with higher payables and inventory (inventory days 67 vs 56; payable days 30 vs 18). Total capital employed was INR 41.99 crore at 30 June 2026. Fixed assets are declining in net terms (INR 18 crore → INR 15 crore), implying capex below depreciation — at odds with management's stated intent to enhance foil and coating capacity.

Cash flow

Source: Screener cash flow (rounded to INR 1 crore). Capex derived as CFO minus FCF. Positive investing inflows in FY2025–FY2026 suggest asset sales, deposit maturities or receipts from the Krish Icons AOP; not itemised in sources accessed.

Commentary — cash flow. Operating cash flow is dominated by working-capital swings in a metal-price-driven business: it was strongly positive in FY2024 (INR 7 crore) when revenue fell and working capital released, used to repay INR 6 crore of debt, and negative in FY2025–FY2026 as the cash conversion cycle lengthened from 71 to 99 days and then 90 days. Cumulative five-year FCF is approximately +INR 1 crore — essentially zero. The company has paid no dividend in at least 12 years (Screener: dividend payout 0% FY2015–FY2026) and has never bought back shares.

Ratios

Computed/6.3 data; FY2022–FY2023 computations use rounded inputs and are approximate. Working-capital days from Screener. ROIC: approximated by Screener ROCE (pre-tax); post-tax ROIC ≈ ROCE × (1 – tax rate), e.g., FY2026 ≈ 3%. Company-reported FY2026 MD&A ratios differ in definition: interest coverage 2.07 (FY2025: 4.14), ROE 0.88% (5.13%), return on net worth 4.14% (9.26%), current ratio 1.75 (1.95), debtor turnover 6.84 (6.85), inventory turnover 7.01 (8.66), debt/equity 0.34 (0.34). The company's "return on net worth" appears to be an EBIT-based measure.

Commentary — ratios. Returns have been below any reasonable cost of equity (Indian micro-cap cost of equity plausibly 14–16%) in every year except FY2022; Screener reports a 3-year average ROE of ~2.7% and 10-year ROE of ~4%. Leverage is modest in balance-sheet terms (D/E 0.34) but meaningful relative to earnings (gross debt/EBITDA ~4.9× in FY2026; interest coverage on the company's own measure halved from 4.14× to 2.07×). The lengthening cash conversion cycle (57 → 90–99 days) is the most important operating deterioration: on FY2026 revenue, each 10 days of CCC ties up ~INR 3.2 crore — roughly 10× FY2026 PAT.

Sources: Screener.in (P&L, balance sheet, cash flows, ratios, quarterly results); FY2026 Directors' Report (financial summary); FY2026 MD&A (key ratios); Simply Wall St (gross profit TTM); JM Financial/Capital Market (Q1 FY2027).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsProducts / servicesStatus

Aluminium Foil

Rolling & conversion (Noida) and printing/lamination (Baddi)

Blister lidding foil, pharma strip foil, cigarette/label foil, tea-chest lining, cheese wrap, household foil, heat-exchanger fin stock, cable wrap, printed foil, foil-paper and foil-poly laminates; glassine paper; BOPP/CPP-based structures

Active — 100% of reported quarterly segment revenue in FY2026 and Q1 FY2027

PVC Film/Sheeting

Calendered PVC films and sheeting; historically also PVC leather cloth (coated fabric)

Shower curtain, auto interior, stationery, insulation tape, rainwear film; PVC leather cloth

Dormant — nil revenue FY2025, FY2026, Q1 FY2027; capital employed INR 282.51 lakh unchanged

Revenue by Segment

Segment / line (INR Cr)FY2024FY2025FY2026

Aluminium Foil revenue (MD&A basis)

89.6096.67110.14

PVC Film/Sheeting revenue (MD&A basis)

0.1600

Reconciling difference to revenue from operations

13.838.637.62

Total revenue from operations

103.59105.30117.76

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment contribution & growth (%)

Segment contribution & growth (%)FY2024FY2025FY2026

Aluminium Foil share of revenue from operations (MD&A basis)

86.591.893.5

PVC share of revenue from operations

0.200

Aluminium Foil YoY growth (MD&A basis)

-14.77.913.9

Total revenue from operations YoY growth

-32.71.711.8

Results by Segment

Aluminium Foil segment result (INR Lakh)Q3 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027

Segment result

81.69-19.3026.6217.68-18.09116.42

Revenue by Segment (30 Jun 2025–30 Jun 2026)

Capital employed (INR Lakh)30 Jun 202531 Mar 202630 Jun 2026

Aluminium Foil

3,767.963,788.773,916.26

PVC Film/Sheeting

282.51282.51282.51

Total

4,050.474,071.284,198.77

Income Statement and Per-Share Data

Metric (INR Cr)FY2022FY2023FY2024FY2025FY2026

Revenue from operations

156154103.59105.30117.76

Operating expenses

150152102.35102.54116.60

Operating profit (EBITDA excl. other income)

621.242.761.16

Other income

212.101.921.50

EBITDA incl. other income

833.344.682.66

Depreciation & amortisation

111.101.211.10

Finance costs

111.131.191.05

Profit before tax

5.700.881.112.280.51

Net profit (PAT)

4.050.570.831.870.33

EPS basic & diluted (INR)

9.851.392.024.550.80

Dividend per share (INR)

00000

Margin & growth (%)

Margin & growth (%)FY2022FY2023FY2024FY2025FY2026

Operating (EBITDA excl. OI) margin

4.11.21.22.61.0

EBITDA margin incl. other income

5.11.93.24.42.3

EBIT margin

4.51.32.23.31.3

PBT margin

3.70.61.12.20.4

Net margin

2.60.40.81.80.3

Revenue growth YoY

77.3-1.3-32.71.711.8

Effective tax rate

2935251835

Income Statement and Margin Analysis (%)

Metric (INR Cr)Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue

29.5025.6428.4719.9823.4528.8028.5424.5126.0534.0728.5329.1132.18

Operating profit

0.330.370.290.250.800.801.090.070.070.530.450.111.43

OPM (%)

1.121.441.021.253.412.783.820.290.271.561.580.384.44

Other income

0.300.910.300.590.360.340.390.830.310.290.290.610.31

PBT

0.070.730.000.310.630.570.910.17-0.140.310.210.131.27

Net profit

0.050.530.000.250.470.400.660.35-0.140.260.150.050.94

EPS (INR)

0.121.290.000.611.140.971.610.85-0.340.630.360.122.29

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet

Metric (INR Cr, 31 March)FY2022FY2023FY2024FY2025FY2026

Equity share capital

4.114.114.114.114.11

Reserves & surplus

3031323334

Total equity (net worth)

3435363738

Total borrowings

1715101313

Other liabilities

1087813

Total liabilities & equity

6158525864

Net fixed assets

1817181615

Capital work-in-progress

01111

Investments

00000

Other assets (current & non-current)

4340334047

Total assets

6158525864

Cash Flow and Margin Analysis (%)

Metric (INR Cr)FY2022FY2023FY2024FY2025FY2026

Cash from operating activities

-137-4-1

Capital expenditure (derived)

11210

Free cash flow

-225-3-1

Cash from investing activities

00021

Cash from financing activities

0-3-62-1

Dividends paid

00000

Share buybacks

00000

CFO / operating profit (%)

-1252546-120-9

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE (%) (PAT / closing equity)

11.91.62.35.10.9

ROA (%) (PAT / total assets)

6.61.01.63.20.5

ROCE (%) (Screener)

144385

Debt / equity (x)

0.500.430.280.350.34

Gross debt / EBITDA incl. OI (x)

2.15.03.02.84.9

Interest coverage (EBIT / interest) (x)

6.71.92.02.91.5

Asset turnover (x) (revenue / total assets)

2.562.661.991.821.84

Debtor days

3035476053

Inventory days

4638405667

Payable days

1515161830

Cash conversion cycle (days)

6157719990

Revenue by Region

Region (INR Cr)FY2025FY2026

Export revenue (foreign exchange earnings)

0.240

Domestic revenue (India, derived)

105.06117.76

Foreign exchange outgo

0.060.01

Growth (%)

Growth (%)FY2026 YoY

Domestic

12.1

Export

-100

Valuation Snapshot

MetricValueSource / date

Last price

INR 66.73

IIFL, 16 Oct 2026

52-week high / low

INR 105 (≈ INR 104.99) / INR 56.5

Screener; Aaj Tak (Aug 2026)

Shares outstanding

41,10,000

FY2026 Directors' Report

Market capitalisation

~INR 27.4 crore

Computed

Face value

INR 10

—

Typical daily volume

Hundreds to low thousands of shares (e.g., 91–3,367 shares on sampled days, Jul–Aug 2026)

Trendlyne; Aaj Tak

Weekly volatility

~8% (higher than 75% of Indian stocks)

Simply Wall St

Price return (%)

Value

—

1 year

-19—

3-year CAGR

4—

5-year CAGR

7—

10-year CAGR

13—

Valuation Multiples

MultipleAmco India (TTM to Jun 2026)Note

P/E

19.6×

On TTM EPS INR 3.40; on FY2026 EPS INR 0.80 the P/E is ~83×

P/B

0.72×

BVPS INR 92.1 (31 Mar 2026)

EV/Sales

0.33×

EV ≈ INR 40.4 crore (market cap INR 27.4 crore + debt INR 13 crore; cash assumed negligible — not disclosed)

EV/EBITDA (incl. other income)

10.1×

TTM EBITDA incl. OI INR 4.02 crore

EV/EBITDA (excl. other income)

16.0×

TTM operating profit INR 2.52 crore

Dividend yield

0%—

Capital Markets

MetricFY2022FY2023FY2024FY2025FY2026

Dividend per share (INR)

00000

Payout ratio (%)

00000

Analyst Conclusions

Management guidance

No quantitative guidance. Qualitative: management expects domestic foil demand to strengthen on pharma capacity expansion and packaging trends, intends to enhance foil and coating capacity, and is pursuing value-added products and new markets; it acknowledges intense competition, raw-material volatility and the need for additional funding.

Consensus expectations

None (no coverage). Analyst framing: if Q1 FY2027 run-rates were sustained (revenue ~INR 32 crore/quarter; OPM ~4%), FY2027 revenue could approach ~INR 125–130 crore and PAT ~INR 3–4 crore (EPS ~INR 7–9). This is an illustrative scenario, not a forecast; Amco's quarterly history (e.g., Q3 FY2025 OPM 3.82% followed by Q4 FY2025 0.29%) argues strongly against extrapolating a single quarter.

Bull case

  1. Operating leverage is real. Q1 FY2027 showed that +23.5% revenue lifted OPM from 0.27% to 4.44% and turned a loss into INR 0.94 crore of PAT — ~2.8× FY2026's full-year profit — demonstrating the earnings sensitivity of a low-fixed-cost converter.

  2. Asset backing limits downside. At 0.72× book (BVPS INR 92.1) with D/E of 0.34, the market values the company below the equity on its balance sheet; foil capital employed alone is INR 39.2 crore vs market cap of INR 27.4 crore.

  3. Structural demand tailwinds. India foil packaging (~USD 1.43 billion, ~5.8% CAGR) and pharma (~USD 60 billion → ~USD 130 billion by 2030) are expanding, and plastic-to-foil substitution supports volumes; foil revenue grew 14% in FY2026 on the company's MD&A basis.

Bear case

  1. No durable margin. OPM has not exceeded 4.4% in 13 quarters and averaged ~1.6% over FY2024–FY2026; FY2026's foil segment essentially broke even (~INR 6.9 lakh), with PBT reliant on other income.

  2. Cash and capital allocation do not compound value. Five-year cumulative FCF ≈ INR 1 crore; ROE averaged ~2.7% over three years; PVC capital idle; real-estate AOP outside core competence; CMD pay exceeded FY2026 PAT; no dividends in 12+ years.

  3. Governance and liquidity discounts are justified. Unresolved BSE SOP fines and promoter demat freeze, combined Chair/MD, promoter on the Audit Committee, zero institutional ownership, no analyst coverage, and trading volumes of a few hundred shares a day make price discovery unreliable (e.g., +20% in one day, fully reversed within three months).

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhat to watch
Q2 FY2027 resultsBy mid-Nov 2026Whether OPM holds above ~3% and revenue above ~INR 30 crore
Q3 FY2027 resultsBy mid-Feb 2027Consistency; working-capital trend
FY2027 audited resultsBy end-May 2027Full-year PAT vs ~INR 0.33 crore base; CFO turning positive
BSE decision on SOP-fine waiverUncertainResolution of promoter demat freeze
Capacity enhancement announcementUncertainQuantum, funding (debt vs equity), timeline
PVC segment decisionUncertainRevival, sale or write-off of INR 2.83 crore capital employed
Krish Icons AOPOngoingProfit share recognition and cash repatriation
Statutory auditor rotation40th AGM (2027)V. V. Kale & Co. term ends; new auditor appointment
Aluminium price and INR/USDContinuousInventory gains/losses; pass-through lags
Regulatory changes in tobacco/pan masala packagingContinuousDemand risk for new applications

Analyst verdict

Amco India Limited is best understood not as the "PVC leather cloth and aluminium foil" company its data-feed descriptions suggest, but as a single-product, sub-scale aluminium foil converter with a dormant PVC legacy and a small real-estate side interest. Its foil franchise is genuine — four decades of operating history, a full conversion chain across Noida and Baddi, and references among recognised Indian pharmaceutical companies — and its balance sheet is unencumbered by heavy debt. Those attributes explain why the stock trades on asset value (0.72× book) rather than collapsing on earnings.

The problem is economic, not existential. Over FY2024–FY2026 the company converted roughly INR 327 crore of cumulative revenue into about INR 5.2 crore of operating profit and INR 3.0 crore of net profit, with near-zero cumulative free cash flow and returns on equity far below any credible cost of capital. Other income has repeatedly been the difference between profit and loss. Management offers direction (pharma focus, value-added products, capacity enhancement) without numbers, timelines or funding plans, and it has not addressed the idle PVC assets or the long-pending BSE governance matter.

Q1 FY2027 is the most encouraging datapoint in three years: a 4.44% operating margin and INR 0.94 crore of quarterly profit show what modest volume growth can do to a low-fixed-cost converter. But Amco has produced isolated strong quarters before, and the market's round trip from INR ~63 to INR ~80 and back to INR ~67 shows that investors share that scepticism.

On balance, Amco is a deep-value, high-uncertainty micro-cap whose upside depends on sustaining Q1-type margins for several consecutive quarters while restoring cash generation. Until that is evidenced — and until governance overhangs are resolved — the book-value discount appears warranted rather than anomalous. Position sizing, if any, should reflect extreme illiquidity and the absence of independent coverage.


APPENDIX A — DATA DISCREPANCIES NOTED

ItemSource ASource BTreatment
FY2026 aluminium foil revenueMD&A: INR 11,013.62 lakhQuarterly segment filings: foil = 100% of revenue from operations (~INR 11,776 lakh)Both shown; difference labelled "reconciling difference"
Noida foil capacityWebsite infrastructure page: 4,800 MTPAWebsite products page: 2,400 MT foil p.a.Both shown; unresolved
FY2026 operating marginScreener annual row: 1.7%Screener quarterly sum: 1.0% (reconciles to audited PBT)Quarterly-reconciled figure used
EmployeesFY2026 MD&A: 79Simply Wall St (S&P): 72Company figure used as latest
CMD compensationFY2026 Directors' Report: INR 85.31 lakhSimply Wall St: INR 6.05 million (likely FY2025)Company figure used for FY2026
Largest shareholderMarketsMojo: Surender Kumar Gupta 17.94%Simply Wall St top list omits him; shows Rajeev Gupta 16.03%Both listed; reconciles to 65.55% promoter total
Q1 FY2027 EPSCompany: INR 2.30Screener: INR 2.29Rounding
Q1 FY2024 revenueScreener: INR 29.50 croreINDmoney: INR 29.80 croreScreener used
CFO roleMarketScreener: Rhea Gupta CFO since 2018Simply Wall St: Rajeev Gupta was CFO until a recent date; Emkay lists four directors excluding Rhea Gupta—

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure / appointmentBackground, education, ageFY2026 remuneration

Rajeev (Kumar) Gupta (DIN 00025410)

Chairman & Managing Director; Audit Committee member

Whole-Time Director since 27 Aug 1987; CMD since 21 Jun 2024; previously also CFO (S&P data)

Promoter; ~39 years with the company. Education and age: not publicly disclosed in sources accessed

Salary INR 60.00 lakh + perquisites INR 25.31 lakh = INR 85.31 lakh (fixed INR 5 lakh/month; no performance-linked pay; no stock options; 1-month notice)

Vidhu Gupta (DIN 00026934)

Director (promoter group); NRC member

Long-standing (date not disclosed)

Promoter family; holds 4.21%

Not disclosed separately

Prarthana Gupta

Independent Director; Chair of Nomination & Remuneration Committee; Audit Committee member

Appointed 21 Jun 2024 (ratified at 37th AGM)

—

No sitting fees paid

Naseem Ahmad

Independent Director; Chair of Audit Committee; NRC member

Date not disclosed

—

No sitting fees paid

Neeraj Gupta

Additional Director (Independent, Non-Executive)

From 27 Aug 2026; subject to approval at 39th AGM

——

Rhea Gupta

Director of Finance / CFO (per MarketScreener from 13 Sep 2018)

—

Graduate degrees from University College London and Jesus & Mary College (Delhi) per MarketScreener; holds 1.22%

—

Company Secretary & Compliance Officer

KMP

~4.8 years tenure (S&P data)

—

~INR 43,600 (as reported by Simply Wall St; period/basis unclear)

“—” = not publicly disclosed.

Directors' Remuneration

AttributeFY2026 position

Board size

4 through FY2026; 5 after 27 Aug 2026

Independence

2 of 4 independent (50%); 3 of 5 after Neeraj Gupta's appointment (60%)

Chair / CEO separation

No — combined Chairman & Managing Director (promoter)

Women directors

2 (Vidhu Gupta, Prarthana Gupta)

Board meetings

6 in FY2026

Committees

Audit (Naseem Ahmad – Chair; Prarthana Gupta; Rajeev Gupta); Nomination & Remuneration (Prarthana Gupta – Chair; Naseem Ahmad; Vidhu Gupta); Stakeholders Relationship; Internal Complaints Committees (Baddi, Noida)

Separate ID meeting

16 Mar 2026

Independent director compensation

No sitting fees; IDs hold no shares

Board changes FY2026

None; KMP changes: none

Policies

Whistle-blower, NRC, RPT materiality, risk management, insider trading code — hosted on website

Board & Management Changes

DateChangeContext

21 Jun 2024

Rajeev Gupta elevated from Whole-Time Director to Chairman & MD

Approved at 37th AGM

21 Jun 2024

Prarthana Gupta appointed Independent Director

Approved at 37th AGM

27 Aug 2026

Neeraj Gupta appointed Additional Independent Director

For approval at 39th AGM (30 Sep 2026)

Shareholding Pattern

Category (%)Jun 2024Jun 2025Jun 2026

Promoters & promoter group

65.5565.5565.55

Government (PICUP)

2.432.432.43

Public / non-institutional

32.0132.0232.03

Number of shareholders

2,8873,0673,032

Major Shareholders

HolderCategorySharesStake (%)Source / date

Surender Kumar Gupta

Promoter

~737,300 (derived)

17.94

MarketsMojo, Jun 2026

Rajeev Gupta

Promoter (CMD)

658,75016.03

Simply Wall St (S&P), 2025

Vijay Laxmi Gupta

Promoter

399,3009.72

Simply Wall St

AMC Coated Fabrics Pvt Ltd

Promoter group (corporate)

396,1759.64

Simply Wall St

Raju Ajit Bhandari

Public

220,9625.38

Simply Wall St; MarketsMojo

Poonam Gupta

Promoter

175,1004.26

Simply Wall St

Vidhu Gupta

Promoter (Director)

173,0534.21

Simply Wall St

S. Sangeetha

Public

149,1253.63

Simply Wall St

Pradeshiya Industrial & Investment Corporation of UP (PICUP)

Government/DII

100,0002.43

Simply Wall St; BSE

Hitesh Javeri

Public

70,2001.71

Simply Wall St

Harsha Javeri

Public

70,0001.70

Simply Wall St

Rupashi Gupta

Promoter

50,0001.22

Simply Wall St

Rhea Gupta

Promoter

50,0001.22

Simply Wall St

Surender Kumar Gupta HUF

Promoter

~54,000 (derived)

~1.31 (derived residual)

Derived from 65.55% total

Competitive Landscape

Key Competitors

#CompetitorSegment overlapScale / revenueRelative positioning vs Amco
1

Hindalco Industries (incl. foil & packaging business)

Aluminium foil (integrated from bauxite to foil)

Consolidated revenue > INR 2 lakh crore (FY2025, approx.)

Dominant integrated player; metal security and scale Amco cannot match

2

Jindal (India) Ltd / Jindal Aluminium group foil units

Aluminium foil

—

Larger rolling capacity; competes in plain and converted foil

3

Raviraj Foils Ltd

Aluminium foil, pharma and packaging

—

Listed small-cap peer; direct overlap in pharma foil

4

Uflex Ltd

Flexible packaging incl. pharma laminates

—

Integrated films + converting; captures laminate value Amco sells into

5

Bilcare Ltd

Pharma packaging films/foils

—

Specialist pharma packaging; R&D-led

6

ACG (Associated Capsules Group) — ACG Pharmapack (unlisted)

Pharma blister films and foils

—

Global-scale pharma packaging specialist

7

Constantia Flexibles (India operations) / Amcor (India)

Pharma & food flexible packaging incl. foil laminates

—

Multinational converters with global pharma accounts

8

Sacheta Metals Ltd

Aluminium foil containers/foil products

—

Listed micro-cap peer named by Business Standard

9

Sudal Industries Ltd

Aluminium products (extrusions)

—

Listed micro-cap aluminium peer (BS peer list); limited direct overlap

10

Essen Speciality Films Ltd

PVC/plastic films & sheets

—

Listed peer for the dormant PVC segment (Emkay peer list)

11

Chinese foil imports

Plain and converted foil

—

Price-setting competition flagged by MD&A (for PVC explicitly; foil exposure implied)

12

Unorganised/regional converters (Baddi, Daman, Ahmedabad clusters)

Pharma printed foil

—

Fragmented, price-competitive; same customer base

Peer Comparison FY2026

MetricAmco IndiaHindalco (integrated leader)

Revenue (latest FY)

INR 117.8 cr (FY2026)

INR 2 lakh cr (FY2025, approx.)

Revenue growth

+11.8% (FY2026)

—

Operating margin

1.0% (FY2026)

—

R&D intensity

0%

Not disclosed here

Exports

Nil (FY2026)

Large

Recent Developments

*Pending: Q2 FY2027 results (quarter ended 30 Sep 2026) due by mid-November 2026 under LODR timelines; board-meeting date not yet verified.

Company Snapshot

$13.6M

Revenue

79

Employees

$3.2M

Market Cap

1987

Founded

SWOT Analysis

Strengths

  • Established pharma customer base: Website lists Cipla, Hetero, Ajanta Pharma, USV, Aditya Dispomed; MD&A describes blister/strip packs as specialty products accepted by leading pharma firms
  • Integrated foil conversion chain: Noida rolling, annealing (Junker), 2 laminators, 2 coaters, beta gauge; Baddi 4 gravure lines, slitters, QC lab (website)
  • Conservative balance sheet: D/E 0.34 (FY2026 MD&A); net worth ~INR 38 crore vs borrowings ~INR 13 crore
  • Stable, committed promoter group: Promoter holding 65.55% since FY2023, no pledges (BSE; MarketsMojo); promoter holding up from 62.64% in FY2017
  • Revenue resilience in foil: Foil revenue (MD&A basis) +7.9% FY2025 and +13.9% FY2026; Q1 FY2027 +23.5%
  • Clean audit record: Statutory, cost, internal and secretarial audit reports for FY2026 carry no qualifications (FY2026 Directors' Report)
  • Asset-backed valuation: Trades at ~0.72× book (INR 66.73 vs BVPS INR 92.1)

Weaknesses

  • Wafer-thin margins: OPM 1.0% FY2026, 2.6% FY2025, 1.2% FY2024; FY2026 foil segment result ≈ INR 6.9 lakh on ~INR 118 crore revenue
  • Earnings dependent on other income: Other income INR 1.50 crore vs operating profit INR 1.16 crore in FY2026
  • Sub-par returns: ROE 0.88% FY2026 (MD&A); 3-year average ~2.7% (Screener)
  • Dormant PVC segment tying up capital: PVC revenue nil FY2025–FY2026; capital employed INR 282.51 lakh unchanged
  • Zero R&D and no technology partnerships: FY2026 Directors' Report: no R&D expenditure; no imported technology in three years
  • Deteriorating working capital: CCC 57 days (FY2023) → 99 (FY2025) → 90 (FY2026); inventory days 67 (FY2026)
  • Weak free cash generation: Five-year cumulative FCF ≈ +INR 1 crore; FCF negative in FY2025 and FY2026
  • High managerial pay relative to profit: CMD remuneration INR 85.31 lakh vs PAT INR 33.10 lakh (FY2026)

Opportunities

  • Growing India foil packaging market: ~USD 1.43 billion, ~5.8% CAGR to 2030 (FY2026 MD&A)
  • Pharma market expansion: India pharma ~USD 60 billion → ~USD 130 billion by 2030 (FY2026 MD&A)
  • Plastic-to-foil substitution: MD&A: foil replacing polyester, LD/HD films; regulatory emphasis on recyclable materials
  • New applications: Cigarette, milk-powder, medical/surgical, pan masala foil (FY2026 MD&A)
  • Operating leverage on volume: Q1 FY2027: +23.5% revenue lifted OPM to 4.44% and PAT to INR 0.94 crore
  • Monetisation or redeployment of PVC assets / real-estate AOP proceeds: INR 2.83 crore PVC capital employed; Krish Icons unit sales underway
  • Export re-entry: Website states intent to enter international markets; FY2025 forex earnings INR 23.96 lakh show some prior capability

Threats

  • Aluminium price swings: Revenue +77% FY2022, -33% FY2024 (Screener)
  • Currency volatility: MD&A states rupee movements significantly impacted foil sales
  • Import competition: MD&A cites pressure from China and other low-cost countries (PVC), plus intense competition generally
  • Regulatory risk in tobacco/pan masala end-uses: MD&A positions these as growth applications; Indian regulation of these products is volatile
  • Exchange regulatory overhang: BSE-ordered freeze of promoter demat accounts over SOP fines; waiver pending since Dec 2023
  • Funding needs: MD&A: company continues to require additional funds for working capital and long-term capital
  • Customer concentration (unquantified): Pharma-heavy customer list; no concentration disclosures

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
30 May 2025Board approves FY2025 audited results: PAT INR 1.87 crore (vs INR 0.83 crore), revenue INR 105.3 croreBest profit since FY2022
15 Jun 2025FY2025 results published in Financial Express and Jansatta; copies filed with BSE 24 Jun 2025Compliance
27 Jun 2025BSE surveillance seeks clarification on price movementSpeculative trading in illiquid stock
28 Jun 2025Company replies no undisclosed price-sensitive information; movement market-drivenCloses surveillance query
30 Jun 2025Trading window closedRoutine
14 Aug 2025Q1 FY2026 results: net loss INR 0.14 crore; sales +11% to INR 26.05 crore; OPM 0.27%First quarterly loss in visible series
22 Aug 2025Board appoints secretarial auditors (5 yrs), cost auditors; approves new AoAGovernance
3–5 Sep 2025FY2025 Annual Report and 38th AGM notice; book closure 24–30 Sep 2025Compliance
30 Sep 202538th AGM via VC; scrutiniser's report filed 2 Oct 2025Approvals incl. AoA and secretarial auditor
4 Nov 2025Q2 FY2026 results: sales INR 34.07 crore (highest quarterly sales in series), PAT INR 0.26 crore (down 35% YoY); registered office shift approvedRevenue high, margin compression
5 Nov 2025Registered office moves to D-948 New Friends Colony, New DelhiAdministrative
6 Nov 2025Q2 results newspaper publication filedCompliance
21 Dec 2025Newspaper notice on special window for re-lodgement of physical share transfersRegulatory
27 Dec 2025Trading window closureRoutine
21 Jan 2026Shareholding pattern Dec 2025 (promoters 65.55%) and Reg. 74(5) certificateRoutine
10 Feb 2026Q3 FY2026 results: revenue INR 2,852.53 lakh (flat YoY), PAT INR 15.11 lakh (-77% YoY); foil segment result INR 17.68 lakh vs INR 81.69 lakhMargin erosion
10 Feb 2026Internal auditor (Sumit R Kumar & Co.) appointed for FY2026Governance
16 Mar 2026Separate meeting of independent directorsGovernance
28 Mar 2026Trading window closureRoutine
20 Apr 2026Shareholding pattern Mar 2026 filedRoutine
30 Apr 2026Initial disclosure under SEBI large-corporate framework (Annexure A)Routine; company is not a large corporate by size
26 May 2026Annual Secretarial Compliance Report (Reg. 24A) filed; no adverse remarksCompliance
30 May 2026FY2026 audited results: revenue INR 117.8 crore (+12%), PAT INR 33.10 lakh (-82%); Q4 PAT INR 5.46 lakh (-84% YoY)Weak year
25 Jun 2026Trading window closureRoutine
Early Jul 2026Stock makes new 52-week low (~INR 56.5–63)Sentiment trough
22 Jul 2026Q1 FY2027 results: revenue INR 3,217.92 lakh (+23.5% YoY), PBT INR 127.49 lakh, PAT INR 94.34 lakh (vs loss INR 13.90 lakh), OPM 4.44%, EPS INR 2.30Turnaround quarter
23 Jul 2026Shares rise ~20% (upper circuit) to ~INR 80.46Market reaction
27 Aug 2026Board approves FY2026 Directors' Report; appoints Neeraj Gupta as Additional Independent Director; reappoints cost auditor for FY2027Governance
5–7 Sep 2026FY2026 Annual Report; 39th AGM notice (AGM 30 Sep 2026); 829 physical letters dispatched to shareholders without emailCompliance
30 Sep 202639th AGM scheduled (accounts, director reappointment, ID appointment, cost auditor remuneration)–
16 Oct 2026Stock closes INR 66.73, back below post-results spikeGains fully reversed

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue from operations fell from INR 1,560 Mn in FY2022 to INR 1,177.6 Mn in FY2026.
Amco India Limited — Income Statement: Revenue & Gross Profit
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Revenue from operations1,5601,5401,035.91,0531,177.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Amco India Ltd, 39th Annual Report FY2026 — Directors' Report (dated 27 Aug 2026), as published by IIFL (indiainfoline.com)
  2. Amco India Ltd, FY2026 Management Discussion & Analysis (dated 27 Aug 2026), as published by IIFL (indiainfoline.com)
  3. Screener.in — Amco India Ltd (financials, quarterly results, shareholding, announcements; data by C-MOTS) (screener.in)
  4. Amco India Ltd website — home/infrastructure · products
  5. BSE filing — reply to clarification on price movement, 28 Jun 2025 (bsmedia.business-standard.com)
  6. BSE filing — FY2025 results newspaper publication, 24 Jun 2025 (bsmedia.business-standard.com)
  7. BSE filing — FY2024 Annual Report / 37th AGM notice (bseindia.com)
  8. Equitybulls — Q1 FY2027 results release (equitybulls.com)
  9. AskFuzz — Q1 FY2027 results summary (askfuzz.ai)
  10. ScanX — Q1 FY2027 results (scanx.trade)
  11. ScanX — Q3 FY2026 results (scanx.trade)
  12. ScanX — company page (events, filings) (scanx.trade)
  13. JM Financial / Capital Market — Q1 FY2027 results (jmfinancialservices.in)
  14. MarketsMojo — Q1 FY2027 result analysis (marketsmojo.com)
  15. MarketsMojo — shareholding (Jun 2026) (marketsmojo.motilaloswal.com)
  16. MarketsMojo — company CV (marketsmojo.motilaloswal.com)
  17. Simply Wall St — overview, management, ownership, valuation (S&P Global Market Intelligence data) (simplywall.st)
  18. Emkay Global — company overview (management, incorporation, name change) (emkayglobal.com)
  19. Emkay Global — company news (emkayglobal.com)
  20. IIFL — company summary/history (indiainfoline.com)
  21. Groww — company page (FY2024 segment revenue reference) (groww.in)
  22. Trendlyne — shareholding and price data (trendlyne.com)
  23. Business Standard — company page (business-standard.com)
  24. Univest — Q1 FY2027 share-price reaction (univest.in)
  25. Sharekhan — company history (pre.sharekhan.com)
  26. MarketScreener — Rhea Gupta profile (uk.marketscreener.com)
  27. ROIC.ai — company description (roic.ai)
  28. Aaj Tak Business — price/market data (Aug 2026) (aajtak.in)
  29. INDmoney — quarterly results history (indmoney.com)

End of dossier. All figures standalone, INR, fiscal years ending 31 March unless stated.

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.